π Join us at ESMO 2025! π
Today we will be presenting poster FPN 550P:
"Retrospective analysis of molecular resistance biomarkers to trastuzumab deruxtecan (T-DXd) in metastatic breast cancer (mBC)"
π : Poster Area, ESMO 2025
π : Today at 12:00 PM
#ESMO2025 #BreastCancer
20.10.2025 09:23 β π 1 π 0 π¬ 0 π 0
π’ Join us at #ESMOBC25 today at 12:00 in the Poster Area!
𧬠154P β Young BRCA+ TNBC: outcomes by histology
π 353P β PostβT-DXd strategies in HER2+ mBC
Iβll be next to poster 353P and happy to discuss both. Stop by for a chat!
#BreastCancer #Oncology #TNBC #HER2 #ESMOBC
15.05.2025 07:06 β π 0 π 0 π¬ 0 π 0
Redirecting
𧬠Just out!
Our review on radioligand therapy in mBC is now published in Cancer Treatment Reviews.
Huge thanks to the whole team, especially Carmen Criscitiello for her mentorship.
π doi.org/10.1016/j.ct...
#breastcancer #RLT #precisionmedicine #theranostics #nuclearmedicine #oncology
10.04.2025 12:14 β π 2 π 0 π¬ 0 π 0
Postdoc, Oslo University Hospital
Translational researcher
Lung cancer β> GIST
π§¬genomic complexity as a biomarker and its role in tumor biology
π§« cancer cell plasticity and treatment adaptation
Medical Doctor | Clinical Artificial Intelligence | Professor of Medicine and Computer Science at TU Dresden, Germany | X: jnkath | web: www.kather.ai
Associate Professor (Docent) in bioinformatics with an interest in cancer, gene signatures and the cell cycle at Karolinska Institutet
Neuro-oncologist @iov_irccs | PhD in Oncology Immunology @UniPadova | Young Neuro-Oncologist 2024-2027 @EORTC Brain Tumor Group
Cancer Evolution and Genome Instability Lab Francis Crick Institute. Views my own
Group leader @gustaveroussy.fr. Computational Oncology π» | Cancer genomics 𧬠| Clonal Hematopoiesis and Leukemiaπ©Έ
Clinician-Scientist, ESMO Ambassador, focussed on Liver Cancer & Precision Oncology, Toronto General Hospital/Princess Margaret Cancer Center π¨π¦/MHHπ©πͺ
The European Association for Cancer Research has 14,000+ members. Our aim? Advancing cancer research π₯Όπ¬π #KeepResearchCurious
www.eacr.org
We (The World Health Organization) are the United Nationsβ health agency championing Health For All. Always check the latest posts for updated advice/information. We will remove misinformation, spam, and hate speech here.
Welcome to The Lancet, one of the worldβs leading medical journals, published weekly since 1823.
π thelancet.com
EU regulatory authority working for public and animal health.
We ensure that all medicines available on the EU market are high quality, safe and effective. Based in Amsterdam.
https://www.ema.europa.eu/
Follow UICC for news & resources on cancer prevention, treatment, and care. Join us in prioritising #cancercontrol and reducing the global #cancer burden.
Empowering impact makers with mission-critical insights. Together, we advance human progress and build global connections.
Cutting-edge research, news, commentary, and visuals from the Science family of journals. https://www.science.org
Nature Reviews Cancer is a monthly review journal for researchers working on cancer. We, the editors, highlight the most exciting topics in cancer research.
https://www.nature.com/nrc/
Metascience and innovative methods to improve population health
Co-Editors-in-Chief: @andreatricco.bsky.social and @davidit.bsky.social
Jclinepi.com
Published by Elsevier
The Lancet Oncology is the global leader in clinical oncology publishing peer-reviewed research and reviews, comment, news, and Commissions. IF=35Β·9.
π https://www.thelancet.com/journals/lanonc/home
News and information from the European Commission. Social media and data protection policy: http://europa.eu/!MnfFmT
Senior Lecturer & Consultant Medical Oncologist in Advanced #Immunotherapy + #CellTherapy at The University of Manchester & The Christie β’ MANIFEST Deputy Lead β’ ESMO #TranslationalResearch Faculty Lead
π Bio: bit.ly/Christie_JonLim
(tennis enthusiast πΎ)